The small print is such a downer -- the new medication is not recommended for people who have severe kidney damage and it is also associated with more frequent death and infection than placebo. I think money is not the best motivation for medication development.
I'm delighted to hear Bill is enjoying visits more.
greetings,
Julie
No comments:
Post a Comment